Skip to main content

Advertisement

SpringerLink
Log in

Cardiac assist device infections

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Cardiac assist devices have emerged as an increasingly important option for circulatory support in patients with advanced congestive heart failure. Infection has been the leading cause of death with use of ventricular assist devices for the past 25 years, and continues to be a major cause of morbidity and mortality in this population. Infections may involve the internal (blood-containing) components, or occur on the external device surfaces. The pump pocket and the percutaneous driveline are particularly vulnerable. In this article we review the pathogenesis, epidemiology, clinical course, and approaches for treatment and prevention of cardiac assist device infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Miller LW, Pagani FD, Russell SD, et al.: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885–896.

    Article  PubMed  CAS  Google Scholar 

  2. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435–1443.

    Article  PubMed  CAS  Google Scholar 

  3. Simon D, Fischer S, Grossman A, et al.: Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005, 40:1108–1115.

    Article  PubMed  Google Scholar 

  4. Oz MC, Gelijns AC, Miller L, et al.: Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 2003, 238:577–583; discussion 583–585.

    PubMed  Google Scholar 

  5. Monkowski DH, Axelrod P, Fekete T, et al.: Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 2007, 9:114–120.

    Article  PubMed  CAS  Google Scholar 

  6. Shoham S, Shaffer R, Sweet L, et al.: Candidemia in patients with ventricular assist devices. Clin Infect Dis 2007, 44:e9–12.

    Article  PubMed  Google Scholar 

  7. Zierer A, Melby SJ, Voeller RK, et al.: Late-onset driveline infections: the Achilles’ heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007, 84:515–20.

    Article  PubMed  Google Scholar 

  8. Arrecubieta C, Asai T, Bayern M, et al.: The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis 2006, 193:1109–1119.

    Article  PubMed  CAS  Google Scholar 

  9. Asai T, Lee MH, Arrecubieta C, et al.: Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus. J Thorac Cardiovasc Surg 2007, 133:1147–1153.

    Article  PubMed  CAS  Google Scholar 

  10. Padera RF: Infection in ventricular assist devices: the role of biofilm. Cardiovasc Pathol 2006, 15:264–270.

    Article  PubMed  CAS  Google Scholar 

  11. Kimball PM, Flattery M, McDougan F, Kasirajan V. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Ann Thorac Surg 2008, 85:1656–1661.

    Article  PubMed  Google Scholar 

  12. Kimball P, Flattery M, Kasirajan V: T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support. Transplant Proc 2006, 38:3695–3696.

    Article  PubMed  CAS  Google Scholar 

  13. Yamani MH, Chuang HH, Ozduran V, et al.: The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. J Heart Lung Transplant 2006, 25:820–824.

    Article  PubMed  Google Scholar 

  14. Gonzalez-Stawinski GV, Cook DJ, Chang AS, et al.: Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 2006, 25:613–618.

    Article  PubMed  Google Scholar 

  15. Schulman AR, Martens TP, Christos PJ, et al.: Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J Thorac Cardiovasc Surg 2007, 133:841–842.

    Article  PubMed  Google Scholar 

  16. Shive MS, Salloum ML, Anderson JM: Shear stress-induced apoptosis of adherent neutrophils: a mechanism for persistence of cardiovascular device infections. Proc Natl Acad Sci U S A 2000, 97:6710–6715.

    Article  PubMed  CAS  Google Scholar 

  17. Shive MS, Brodbeck WG, Colton E, Anderson JM: Shear stress and material surface effects on adherent human monocyte apoptosis. J Biomed Mater Res 2002, 60:148–158.

    Article  PubMed  CAS  Google Scholar 

  18. Shive MS, Hasan SM, Anderson JM: Shear stress effects on bacterial adhesion, leukocyte adhesion, and leukocyte oxidative capacity on a polyetherurethane. J Biomed Mater Res 1999, 46:511–519.

    Article  PubMed  CAS  Google Scholar 

  19. Pae WE, Connell JM, Adelowo A, et al.: Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 2007, 26:219–229.

    Article  PubMed  Google Scholar 

  20. Holman WL, Pamboukian SV, Blood M, et al.: Managing device infections: are we progressing or is infection an insurmountable obstacle? Asaio J 2005, 51:452–455.

    Article  PubMed  Google Scholar 

  21. Holman WL, Rayburn BK, McGiffin DC, et al.: Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg 2003, 75:S48–S57.

    Article  PubMed  Google Scholar 

  22. Holman WL, Pamboukian SV, Bellot SC, et al.: Use of an intraperitoneal ventricular assist device with a polytetra-fluoroethylene barrier decreases infections. J Heart Lung Transplant 2008, 27:268–271.

    Article  PubMed  Google Scholar 

  23. Baradarian S, Stahovich M, Krause S, et al.: Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. Asaio J 2006, 52:354–356.

    Article  PubMed  Google Scholar 

  24. Holman WL, Park SJ, Long JW, et al.: Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004, 23:1359–1365.

    Article  PubMed  Google Scholar 

  25. Huang R, Deng M, Rogers JG, et al.: Effect of age on outcomes after left ventricular assist device placement. Transplant Proc 2006, 38:1496–1498.

    Article  PubMed  CAS  Google Scholar 

  26. Granfeldt H, Hellgren L, Dellgren G, et al.: Experience with the Impella(R) recovery axial-flow system for acute heart failure at three cardiothoracic centers in Sweden. Scand Cardiovasc J 2009:1–7.

  27. El-Hamamsy I, Jacques F, Perrault LP, et al.: Results following implantation of mechanical circulatory support systems: the Montreal Heart Institute experience. Can J Cardiol 2009, 25:107–110.

    PubMed  Google Scholar 

  28. Osaki S, Edwards NM, Velez M, et al.: Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience. Eur J Cardiothorac Surg 2008, 34:281–288.

    Article  PubMed  Google Scholar 

  29. Lietz K, Long JW, Kfoury AG, et al.: Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007, 116:497–505.

    Article  PubMed  Google Scholar 

  30. Chinn R, Dembitsky W, Eaton L, et al.: Multicenter experience: prevention and management of left ventricular assist device infections. Asaio J 2005, 51:461–470.

    Article  PubMed  Google Scholar 

  31. Manahan MA, Goldberg NH, Silverman RP. Successful salvage of ventricular-assist devices in the setting of pump pocket infection. Ann Plast Surg 2006, 57:435–439.

    Article  PubMed  CAS  Google Scholar 

  32. Didisheim P, Rose EA, Long JW, et al.: Infection with clinical ventricular assist devices: clinical therapy. Asaio J 2001, 47:195–196.

    Article  PubMed  CAS  Google Scholar 

  33. Yuh DD, Albaugh M, Ullrich S, Conte JV: Treatment of ventricular assist device driveline infection with vacuum-assisted closure system. Ann Thorac Surg 2005, 80:1493–1495.

    Article  PubMed  Google Scholar 

  34. McGee EC, Jr., Cotts W, Tambur AR, et al.: Successful bridge to transplant in a highly sensitized patient with a complicated pump pocket infection. J Heart Lung Transplant 2008, 27:568–571.

    Article  PubMed  Google Scholar 

  35. Sajjadian A, Valerio IL, Acurturk O, et al.: Omental transposition flap for salvage of ventricular assist devices. Plast Reconstr Surg 2006, 118:919–926; discussion 927.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Infectious Diseases, Washington Hospital Center, Room 2A38G, 110 Irving Street, NW, Washington, DC, 20010, USA

    Shmuel Shoham

Authors
  1. Shmuel Shoham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shmuel Shoham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shoham, S., Miller, L.W. Cardiac assist device infections. Curr Infect Dis Rep 11, 268–273 (2009). https://doi.org/10.1007/s11908-009-0040-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0040-4

Keywords

Search

Navigation